Angioimmunoblastic T-cell lymphoma surgery: Difference between revisions
Category |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angioimmunoblastic T-cell lymphoma}} | {{Angioimmunoblastic T-cell lymphoma}} | ||
{{CMG}}, {{AE}}{{Sab}} | |||
==Overview== | |||
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma. | |||
==Surgery== | |||
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma. | |||
==References== | ==References== |
Latest revision as of 21:45, 15 April 2019
Angioimmunoblastic T-cell lymphoma Microchapters |
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Angioimmunoblastic T-cell lymphoma surgery On the Web |
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma surgery |
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma.
Surgery
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma.
References